As of April 2024 Biotest has a market cap of $1.48 Billion. This makes Biotest the world's 4527th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.48 B | -7.49% |
2023 | $1.60 B | -1.72% |
2022 | $1.63 B | -10.34% |
2021 | $1.82 B | 31.56% |
2020 | $1.38 B | 57.37% |
2019 | $0.87 B | -21.46% |
2018 | $1.12 B | 10.78% |
2017 | $1.01 B | 65.02% |
2016 | $0.61 B | -16.92% |
2015 | $0.73 B | -49.83% |
2014 | $1.47 B | 4.82% |
2013 | $1.40 B | 80.4% |
2012 | $0.77 B | 25.06% |
2011 | $0.62 B | -17.83% |
2010 | $0.75 B | 15.75% |
2009 | $0.65 B | -26.85% |
2008 | $0.89 B | 46.07% |
2007 | $0.61 B | 47.37% |
2006 | $0.41 B | 34.48% |
2005 | $0.30 B | 137.04% |
2004 | $0.13 B | 77.11% |
2003 | $73.52 M |
On Apr 18th, 2024 the market cap of Biotest was reported to be: